SCHEMBL2908104

SCHEMBL2908104

O=S(=O)(CCl)NCc1ccc(Cl)cc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 6/20 0.68
KMT2A Q03164 6/20 0.68
GAA P10253 2/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
ALDH1A1 P00352 5/20 0.49
RECQL P46063 1/20 0.49
MAPK1 P28482 1/20 0.49
HSD17B10 Q99714 1/20 0.49
CYP19A1 P11511 1/20 0.46
ERCC1 P07992 1/20 0.44
ERCC4 Q92889 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
POLB P06746 1/20 0.43
CA12 O43570 1/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
CA4 P22748 1/20 0.42
CA9 Q16790 1/20 0.42
ALOX12 P18054 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5229027 0.79 MEN1 (0.73) MEN1KMT2AGAAL3MBTL1ALDH1A1
SCHEMBL3716044 0.78 HTT (0.61) ALDH1A1CYP19A1CA12CA1CA2
SCHEMBL25171194 0.78 MEN1 (0.70) MEN1KMT2AGAAL3MBTL1ALDH1A1
SCHEMBL14380626 0.78 MEN1 (0.70) MEN1KMT2AGAAALDH1A1RECQL
SCHEMBL6338974 0.78 KMT2A (0.70) MEN1KMT2AGAAL3MBTL1ALDH1A1
SCHEMBL8514619 0.72 MEN1 (0.56) MEN1KMT2AGAAL3MBTL1ALDH1A1
SCHEMBL4662845 0.72 KEAP1 (0.76) MEN1KMT2AGAAL3MBTL1ALDH1A1
SCHEMBL2908147 0.71 CA1 (0.57) MEN1KMT2AGAAALDH1A1CYP19A1
SCHEMBL26212940 0.71 KDM4E (0.51) MEN1KMT2AGAAL3MBTL1ALDH1A1
SCHEMBL5960116 0.69 MEN1 (0.73) MEN1KMT2AL3MBTL1ALDH1A1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1963337-B1 THIENO[2,3-b]PYRIDINE DERIVATIVES RICHTER GEDEON NYRT (HU) 2010-09-01 EP disclosed
US-20100022521-A1 COMPOUNDS HANSA METALLWERKE AG (DE) 2010-01-28 US disclosed
CN-101341152-A Novel compounds RICHTER GEDEON NYRT (HU) 2009-01-07 CN disclosed
EP-1963337-A1 NEW COMPOUNDS Richter Gedeon NYRT (HU) 2008-09-03 EP disclosed
WO-2007072095-A1 NEW COMPOUNDS RICHTER GEDEON NYRT. (HU) 2007-06-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100022521-A1 COMPOUNDS GRM5, GRM3, GRM1 MEN1 4389/4885KMT2A 2168/4885GAA 4754/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.